BHI (083650.KQ) — Analysis Update

Date: 2026-03-16

Current Situation

Metric	Value
Price	₩101,500
Previous Close	₩103,600
Day Change	-2.03%
Open	₩104,800
Intraday Range	₩101,000 – ₩108,300
52-Week High	₩114,200 (Mar 10)
52-Week Low	₩15,270
50-Day MA	₩73,270
200-Day MA	₩52,529
Volume	525,250 (avg 873,575)
Market Cap	₩3.14T

What Changed Since March 6 Analysis

Factor	Mar 6	Mar 16	Change
Price	₩94,800	₩101,500	+7.1%
52-week high	₩98,000	₩114,200	Broke through decisively
Market cap	₩2.93T	₩3.14T	+₩210B
50-day MA	₩67,848	₩73,270	Rising
Foreign ownership	21.91%	20.64%	Declining
KOSDAQ	1,154.67	1,138.29	-1.4%
Key decision point	₩98,000 breakout test	₩98,000 broke; now consolidating post-ATH	Resolved

The ₩98,000 resistance level identified in the March 6 analysis broke decisively on March 9–10, with BHI surging to an all-time high of ₩114,200 on March 10. The stock is now consolidating 11.1% below that peak.

2025 Full-Year Results (New Data)

BHI reported record 2025 results that were not available in the previous analysis:

Metric	2024 (reported)	2025 (actual)	YoY Change
Revenue	₩404.7B	₩771.6B	+90.6%
Operating Profit	₩22.0B	₩73.3B	+233.6%
Net Income	₩19.6B	₩60.6B	+209.2%
Operating Margin	5.4%	9.5%	+4.1pp
EPS	₩633	~₩1,959	+209.5%

The 2025 results transform the valuation picture. Revenue nearly doubled. Operating margins expanded from 5.4% to 9.5%. Net income tripled. The previous analysis noted that "10% revenue growth" couldn't support a 150x P/E — the actual growth was 91%.

Revenue Drivers

HRSG (Heat Recovery Steam Generators) for LNG combined-cycle plants: ~73% of revenue by Q4 2025, high-margin large projects.
Nuclear BOP equipment for Shinhanul Units 3 & 4: revenue recognition began in earnest during 2025.
New orders reached ~₩1.8T for the year — an all-time high.

Valuation (Updated)

Metric	At ₩94,800 (Mar 6)	At ₩101,500 (Mar 16)	Notes
P/E (trailing 2024, EPS ₩633)	~150x	~160x	Stale; 2024 numbers are obsolete
P/E (trailing 2025, EPS ~₩1,959)	~48x	~52x	This is the relevant trailing multiple
P/Book (2024 equity ₩116.4B)	~25x	~27x	2025 equity ~₩177B → P/B ~18x
EV/EBITDA (2025E EBITDA ~₩80B)	~39x	~41x
P/FCF (2024 FCF ₩35.5B)	~83x	~89x	2025 FCF likely higher

Forward Estimates (Analyst Consensus)

Metric	2026E	2027E (extrapolated)
Revenue	₩952.3B (+23%)	₩1,100B–₩1,200B
Operating Profit	₩109.5B (+49%)	₩130B–₩150B
Estimated Net Income	~₩80–85B	~₩100–120B
Implied EPS	~₩2,600–2,750	~₩3,200–3,900
Forward P/E at ₩101,500	~37–39x	~26–32x
Forward EV/EBITDA	~28x	~22–25x

The valuation picture has shifted materially. What was a 150x trailing P/E stock on 2024 numbers is a 52x stock on 2025 actuals and a ~38x stock on 2026 estimates. For an industrial company with 91% revenue growth, a backlog-to-revenue ratio above 2x, and structural sector tailwinds, 37–39x forward earnings is elevated but no longer absurd. The previous analysis correctly noted that institutions were pricing 2027–28 earnings; the 2025 results confirmed the trajectory institutions were betting on.

Analyst Coverage Gap

Shinhan Investment's target of ₩70,000 (set January 15) is now 31% below market. Either analysts are dramatically behind or the stock is ahead of itself. Given that the ₩70,000 target preceded the 2025 results and the Iran war catalyst, it's likely stale. Watch for target revisions.

Iran War — The Structural Macro Catalyst

This is the dominant new development since the previous analysis.

Timeline

Feb 28: US/Israel strikes on Iran. Khamenei killed.
Mar 2: IRGC declared Strait of Hormuz closed.
Mar 3–4: KOSPI crashed 12.1% (worst on record), KOSDAQ -14%. BHI dropped to ₩72,000.
Mar 6: BHI recovered to ₩94,800 (+17.3% in a single session) while KOSPI was flat.
Mar 9–16: Oil fluctuating around $100/bbl (from $65 pre-war). BHI made new ATH at ₩114,200.

Policy Impact on BHI

The Korean government response directly benefits BHI's order pipeline:

Reactor restarts accelerated. Two units targeted for restart in March, four more by mid-May.
Emergency energy security task force activated.
$68.3 billion stabilization fund being established, expected to include accelerated nuclear investment.
Two new large reactors (2.8 GWe) confirmed under 11th Basic Plan. Site selection bids opened with March 30 deadline. Target commercial operation 2037–2038.
Czech Republic (Dukovany): KHNP signed $18.7B main contract for two APR1000 reactors. BHI expects auxiliary equipment orders in Q4 2026 — a concrete near-term catalyst.
Nuclear energy now framed as national security imperative, not just policy preference.

The nuclear-as-counterweight-to-oil thesis identified in the March 6 analysis has been validated and accelerated by actual policy action. This is no longer speculative positioning — the government is spending real money.

The Counterargument (Unchanged)

A prolonged Hormuz closure contracts Korea's economy. Credit tightens. BHI's negative working capital (₩132.6B) makes it dependent on rolling short-term debt. A credit crunch doesn't distinguish nuclear from non-nuclear borrowers. The same crisis that creates the long-term thesis creates the short-term balance sheet risk.

Fundamentals

Income Statement Trajectory

Item	2021	2022	2023	2024	2025 (actual)
Revenue	₩234.9B	₩330.2B	₩367.4B	₩404.7B	₩771.6B
Revenue Growth	—	+40.6%	+11.3%	+10.2%	+90.6%
Gross Margin	-2.7%	10.6%	11.8%	14.6%	—
Operating Margin	-13.0%	2.5%	4.1%	5.4%	9.5%
Net Income	-₩34.6B	-₩19.1B	₩7.5B	₩19.6B	₩60.6B
FCF	-₩18.8B	₩13.7B	₩39.2B	₩35.5B	—

This is no longer a turnaround story. It's a growth story. Revenue nearly doubled in 2025 while margins expanded 4 percentage points. The company has gone from losing ₩34.6B in 2021 to earning ₩60.6B in 2025.

Balance Sheet (End 2024)

Item	Amount	Risk Level
Total Debt	₩126.7B	Decreasing (was ₩212B in 2022)
Net Debt	₩107.8B	Decreasing
Working Capital	-₩132.6B	Structural risk — unchanged
Cash	₩17.6B	Thin relative to liabilities
Current Ratio	0.65x	Weak
Debt/Equity	1.09x	Manageable

The working capital deficit remains the key balance sheet vulnerability. With ₩125.4B in current debt vs near-zero long-term debt, BHI is dependent on rolling over short-term financing. The 2025 earnings (₩60.6B net income) should have improved the 2025 balance sheet materially — retained earnings would move from -₩8.5B to approximately +₩52B — but we don't have the full 2025 balance sheet yet.

Technical Analysis

Price Structure Since Breakout

Date	Event	Price	Volume
Mar 6	Previous analysis	₩94,800	961,342
Mar 9	₩98,000 broken	₩97,700	983,045
Mar 10	All-time high	₩105,000 (high ₩114,200)	1,297,819
Mar 11	Pullback begins	₩100,400	833,045
Mar 12	Consolidation	₩99,700	552,819
Mar 13	Recovery	₩103,600	836,036
Mar 16	Today	₩101,500	525,250

The stock hit ₩114,200 intraday on March 10 but closed at ₩105,000 — a significant upper-wick rejection. Since then, it has traded in a ₩99,000–₩108,000 range with declining volume. Today's volume (525K) is 60% of the 873K average — indicating reduced participation.

Key Levels (Updated)

Level	Price	Notes
All-time high	₩114,200	Resistance; upper-wick rejection on Mar 10
Mar 10 close	₩105,000	Near-term resistance
Current price	₩101,500
Psychological support	₩100,000	Tested today (low ₩101,000)
Previous resistance → support	₩94,800–₩98,000	Former ceiling; should provide strong support
50-day MA	₩73,270	Distant; 38.5% below current price
200-day MA	₩52,529	93% below; long-term floor

Momentum

Indicator	Value	Signal
Price vs 50-day MA	+38.5% above	Extremely extended
Price vs 200-day MA	+93.2% above	Extremely extended
Distance from ATH	-11.1%	Post-breakout consolidation
Volume trend (5-day)	Declining	Reduced participation
Post-ATH pattern	Lower highs, holding ₩99,000–₩100,000	Consolidation, not collapse

Investor Flow Analysis

Cumulative Totals — 100 Trading Days (Oct 16, 2025 – Mar 13, 2026)

Investor Type	Net Shares	% of Outstanding (30.94M)
Institutional	+2,275,637	+7.4%
Foreign	+3,019,708	+9.8%
Retail	-5,295,345	-17.1%

Retail has sold 5.3 million shares — 17.1% of the company — over 100 trading days. Institutions and foreigners absorbed all of it plus additional shares.

Post-Breakout Week (Mar 9–13) — Critical Shift

Date	Close	Chg	Inst Net	Frgn Net	Retail	Frgn %
Mar 9	₩97,700	+3.1%	+157,924	-174,045	+16,121	21.43%
Mar 10	₩105,000	+7.5%	+162,645	-41,965	-120,680	21.01%
Mar 11	₩100,400	-4.4%	+60,045	-173,441	+113,396	20.27%
Mar 12	₩99,700	-0.7%	+42,213	-71,047	+28,834	20.39%
Mar 13	₩103,600	+3.9%	-44,027	+48,136	-4,109	20.64%
Net (5 days)			+378,800	-412,362	+33,562

Foreign investors have been net sellers for 5 consecutive days surrounding the ATH. They sold 412K shares during the post-breakout period — distributing into strength. Foreign ownership dropped from 21.91% (Mar 6) to 20.64% (Mar 13). This is a 1.27 percentage point decline in one week.

Institutions remained net buyers on 4 of 5 days, accumulating 378K shares. They are still the dominant demand source.

Retail was approximately flat — a change from the persistent selling pattern of prior months.

Foreign Ownership Trajectory (Key Shift)

Date	Foreign %	Trend
Jan 7 (block trade)	23.07%	Peak
Feb 13	19.98%	Trimming
Feb 27 (pre-crash)	21.93%	Re-accumulated
Mar 4 (crash)	22.61%	Bought the crash
Mar 6	21.91%	Started selling
Mar 13	20.64%	Continued selling
Trend		Declining since Mar 4

Foreign ownership peaked at 22.61% on the crash day (Mar 4) and has declined every week since. The Jan 7 block trade holder and/or other foreign investors are distributing. At the current pace (~0.6pp/week), they would drop below 20% within 1–2 weeks.

This is the warning signal identified in the March 6 analysis: "A drop below 20% means the strategic holder is trimming; exit accelerates." We're not there yet, but the trajectory is heading there.

Today's Broker Data

Top Sellers	Volume	Top Buyers	Volume
신한투자증권	73,712	한국투자증권	70,983
키움증권	72,771	신한투자증권	61,266
한국투자증권	56,244	키움증권	57,088
제이피모간 (JP Morgan)	48,333	NH투자증권	46,611
삼성증권	38,520	미래에셋증권	34,719

Foreign Estimate: Sell 48,333 | Buy 0 | Net -48,333

JP Morgan is the 4th largest seller and the only identifiable foreign broker. Foreign selling continues today.
키움증권 (retail broker) is the #2 seller and #3 buyer — mixed retail sentiment.
미래에셋 (Mirae Asset, institutional) is a buyer (#5) but with relatively small volume (34,719). Institutional demand is present but weaker than the prior week.

BHI vs KOSDAQ Comparison

6-Month Performance

Period	BHI	KOSDAQ	BHI Outperformance
Sep 16 → Mar 16 (6 months)	+104.6%	+33.6%	+71.0pp
Jan 2 → Mar 16 (YTD)	+92.6%	+23.0%	+69.6pp
Mar 6 → Mar 16 (since last analysis)	+7.1%	-1.4%	+8.5pp

Post-Crash Recovery Comparison

Metric	BHI	KOSDAQ
Pre-crash peak	₩98,000 (Mar 3)	1,215.67 (Mar 3)
Crash low	₩72,000 (Mar 4)	976.54 (Mar 4)
Peak-to-trough	-26.5%	-19.7%
Mar 16 close	₩101,500	1,138.29
Recovery from crash	113.5% (exceeded peak)	67.6%
vs pre-crash peak	+3.6% above	-6.4% below

BHI has fully recovered and surpassed its pre-crash level. KOSDAQ has not. BHI continues to outperform the broad market, consistent with a stock-specific catalyst (nuclear policy + institutional accumulation) rather than a macro-driven recovery.

Today, both declined: BHI -2.03%, KOSDAQ -1.27%. BHI underperformed the index today — part of the post-ATH consolidation.

Assessment

What's Different From March 6

The ₩98,000 breakout happened. The stock entered price discovery, hit ₩114,200, and is now consolidating. The breakout was institutional-driven (+378K shares net in the breakout week).
2025 results confirmed the growth. Revenue +91%, net income +210%. This retroactively justifies much of the institutional accumulation. The trailing P/E on actual 2025 earnings is 52x, not 150x. Forward P/E on 2026 estimates is ~38x.
Foreign investors are distributing. Ownership declined from 22.61% to 20.64% over 8 trading days. They bought the crash and are now selling the breakout. This is the single most important change in the flow dynamics since March 6.
The macro catalyst has intensified. The Iran war has moved from market shock to policy response. Korea is now treating nuclear as a national security imperative, with concrete actions (reactor restarts, new builds, emergency funds). This is structurally bullish for BHI's order pipeline.
Volume is declining post-ATH. Today's 525K is 60% of the average. Reduced participation after a sharp move can indicate either healthy consolidation or exhaustion.

The Bull Case (Stronger Than March 6)

2025 results demonstrate BHI is executing on its backlog. Revenue nearly doubled.
2026 estimates (₩952B revenue, ₩110B operating profit) imply continued 23%+ growth.
Nuclear policy acceleration is no longer speculative — real money and real timelines.
Czech Dukovany orders expected Q4 2026.
Two new domestic reactors confirmed.
At ~38x forward P/E, the stock is expensive for an industrial but not irrational given the growth rate.
Institutional accumulation continues. +378K shares in the breakout week alone.

The Bear Case (Also Stronger Than March 6)

Foreign distribution is accelerating. The strategic holder(s) are taking profits. Foreign ownership is heading toward the 20% threshold identified as a sell signal.
The stock is 38.5% above its 50-day MA. This degree of extension from the moving average historically precedes mean-reversion corrections, even in uptrends.
Upper-wick rejection at ₩114,200. The ATH session (Mar 10) opened at ₩105,800, spiked to ₩114,200, and closed at ₩105,000 — a 9,200-point rejection. This is a negative signal for near-term price action.
Declining volume in consolidation. Could indicate buyers are stepping back.
Analyst targets are stale. The lone published target (₩70,000) is 31% below market. If analysts revise upward, it could trigger another leg higher. If they don't, the market is pricing something analysts don't see.
The valuation still requires execution. 38x forward P/E on ₩80B net income assumes the backlog converts on schedule. Large industrial projects slip. Margins need to hold at 9.5%+ as the company scales.
Balance sheet hasn't changed. ₩132.6B negative working capital. All short-term debt. Iran-driven credit tightening is a real risk.

Net Assessment

BHI's fundamental story has strengthened materially since March 6. The 2025 results confirmed the growth, and the Iran crisis has created a structural policy tailwind. The valuation, when properly calculated on 2025 actuals and 2026 estimates, is elevated but not detached from reality.

The key risk shift is in the flow dynamics. Institutions are still buying, but foreign investors are selling. The March 6 analysis identified foreign ownership below 20% as a sell signal — we're at 20.64% and declining ~0.6pp/week. The foreign distribution, combined with the upper-wick rejection at ₩114,200 and declining volume, suggests the near-term momentum has shifted from "breakout" to "consolidation at best, correction toward ₩94,000–₩98,000 at worst."

The medium-term outlook (3–6 months) remains constructive as long as:

Institutions continue net buying
2026 quarterly results confirm the ₩952B revenue / ₩110B operating profit trajectory
Czech Dukovany orders materialize in Q4 2026
No credit crunch from the Iran crisis

Buy & Sell Strategy

Disclaimer: The following are analytical musings and scenario frameworks, not investment recommendations. Any person executing trades based on this analysis is solely responsible for the decisions they make and any resulting gains or losses.

Buy Strategy

Tranche	Trigger	Entry Zone	Rationale
1	Pullback to previous resistance	₩94,000–₩98,000	Former ceiling is now floor. Institutional buying was active in this zone. Risk/reward favorable.
2	Retest of ₩100,000 with institutional buying confirmed	₩99,000–₩102,000	If daily KRX data shows institutional net positive during the dip, the demand structure is intact.
3	Breakout above ₩114,200 on volume	₩114,200+	New ATH with conviction. Only if volume exceeds 1M shares on the breakout day.
4	Panic dip (second macro shock)	₩80,000–₩85,000	Same playbook as Mar 4. Institutions bought that dip. Only if foreign ownership holds above 19%.

Avoid buying:

In the ₩105,000–₩114,000 range without a clear catalyst — this is the rejection zone from Mar 10.
If foreign ownership drops below 19.5% — suggests the strategic holder is exiting in scale.
If institutional net turns negative for 3+ consecutive days.

Sell Strategy

Tranche	Trigger	Exit Zone	Rationale
1	Limit sell near ATH	₩110,000–₩114,000	Proven resistance. The Mar 10 upper wick shows supply here.
2	Breakout sell	₩120,000–₩130,000	If ATH breaks on volume, ride momentum with trailing stop at ₩108,000.
3	Time-based	After Q1 2026 earnings release	If 2026 Q1 results confirm the ₩952B revenue trajectory, the stock deserves to be held. If they disappoint, exit.
4	Flow-based exit	When foreign ownership drops below 20%	The strategic holder is leaving. Institutional demand alone may not support the stock at these levels.

Hard stop-loss: ₩88,000 (below the institutional support zone and 50-day MA trajectory). A break below this level with institutional net selling = the demand thesis is broken.

Key Metrics to Monitor

Indicator	Current	Warning Level	Action
Foreign ownership %	20.64%	< 20.0%	Reduce position
Foreign ownership %	20.64%	< 19.0%	Exit
Institutional daily net	Positive (4 of last 5 days)	3+ consecutive negative days	Reduce position
Volume on down days	~500K–800K	> 1.5M on a down day	Likely forced selling; evaluate
50-day MA distance	+38.5%	> 50%	Overextended; tighten stops
Support at ₩98,000	Not yet tested as support	Break below on volume	Former resistance failed as support = bearish

Scenario Probabilities (Next 30 Days)

Scenario	Description	Probability	Outcome
Consolidation	₩95,000–₩110,000 range. Volume stays low. Institutions buy dips, foreigners sell rallies.	45%	Sideways; 50-day MA catches up to price.
Breakout to new ATH	Catalyst (Czech order news, analyst upgrade, Q1 preview) drives above ₩114,200.	25%	Target ₩120,000–₩140,000 range.
Correction to support	Foreign selling accelerates, pulls price to ₩94,000–₩98,000. Tests former resistance as support.	20%	Buying opportunity if institutional flow holds.
Sharp correction	Second macro shock or credit event. Retest of ₩80,000–₩85,000.	10%	Test of institutional conviction.

Order Pipeline Summary

Contract / Opportunity	Value	Timeline	Status
Shinhanul 3 & 4 BOP	~₩150B cumulative	Revenue recognition ongoing	Contracted
HRSG projects (Middle East/Asia)	~73% of revenue	Ongoing	Contracted
Czech Republic Dukovany auxiliary equipment	TBD	Q4 2026 expected	Pre-contract
Two new domestic reactors (2.8 GWe)	TBD	Site selection 2026, operations 2037–38	Planning stage
SMR component supply	TBD	Medium-term	Discussions
US market entry via NuScale/other partnerships	TBD	Long-term	Exploratory

Annual new orders for 2026 expected to exceed ₩1T, potentially reaching ₩2T.

Summary

BHI at ₩101,500 is a fundamentally different stock than it was at ₩94,800 on March 6 — not because of the 7% price increase, but because:

2025 results confirmed the growth story. Trailing P/E is 52x on actual earnings, not 150x on stale 2024 numbers. Forward P/E is ~38x with 23% revenue growth ahead.
The Iran crisis created a structural policy catalyst. Nuclear is now national security infrastructure in Korea, with concrete government actions and funding.
The stock broke ₩98,000 and made a new ATH at ₩114,200. The previous analysis's key decision point resolved bullishly.
Foreign distribution is the new risk. Ownership declining from 22.6% toward 20% over 8 trading days. This is the most actionable signal to watch.

The stock is in a transition phase. The parabolic run from ₩15,270 to ₩114,200 (7.5x in one year) is likely entering a consolidation period where the fundamentals (2026 quarterly earnings, Czech orders, new reactor timelines) need to catch up to the price. Institutions are providing a floor. Foreigners are providing a ceiling. The resolution will depend on which side persists — and on whether the next round of catalysts (Q1 earnings, Czech Dukovany, analyst upgrades) arrives before foreign distribution erodes the support structure.